Total planned funding: $1,148,930,926
Clear active filters
HTXD: Treatment: ARV Drugs
Private Contractor
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $294,563,746 |
Zambia | $172,095,655 |
Tanzania | $145,232,379 |
Mozambique | $115,251,433 |
Zimbabwe | $68,296,922 |
Côte d'Ivoire | $67,620,657 |
Rwanda | $50,471,300 |
Uganda | $47,179,030 |
Ethiopia | $39,684,200 |
Kenya | $35,216,278 |
Vietnam | $33,825,620 |
Haiti | $32,481,995 |
Democratic Republic of the Congo | $16,140,079 |
Cameroon | $10,136,747 |
South Africa | $6,194,022 |
Namibia | $3,239,092 |
Guyana | $3,209,493 |
Botswana | $3,055,118 |
Burundi | $2,599,423 |
Eswatini | $1,906,218 |
South Sudan | $214,638 |
Malawi | $150,000 |
Ukraine | $132,881 |
Angola | $34,000 |
Lesotho | $0 |
Organizational Types
Private Contractor | $1,148,930,926 |
Program Areas
Treatment | $1,148,930,926 |
Budget Codes
HTXD: Treatment: ARV Drugs | $1,148,930,926 |
Top Partner Programs
Chemonics International:
$373,400,880
View countries